Kiora Pharmaceuticals KPRX
NASDAQ KPRX
$2.57 -0.03 (-1.15%)
As of: Sep 30, 2026 · 9:30 AM EDT

Kiora Pharmaceuticals Inc (KPRX) Capital Expenditures (2017 - 2026)

Updated

Kiora Pharmaceuticals (KPRX) reported Capital Expenditures of $23,456 for Q2 2026, down 27.1% from $32,195 a year earlier but up 367.4% from the prior quarter.

Analysis

Kiora Pharmaceuticals Inc (KPRX) Capital Expenditures (2017 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Kiora Pharmaceuticals' Capital Expenditures came in at $107,068; for FY2025, it came in at $110,789.

  • Capital Expenditures has a five-year compound annual growth rate of 40.7% (FY2020 to FY2025).
  • By year, Capital Expenditures came in at $6,256 in FY2024 and $63,865 in FY2021 (+218.1%).
  • Five-year quarterly Capital Expenditures spans a low of -$45,031 in Q4 2024 and a high of $78,163 in Q4 2025.
  • Per Business Quant data, the three quarters before Q2 2026 came in at $5,018 (Q1 2026), $78,163 (Q4 2025) and $431.00 (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 23,456.00
Mar 31, 2026 5,018.00
Dec 31, 2025 78,163.00
Sep 30, 2025 431.00
Jun 30, 2025 32,195.00
Dec 31, 2024 -45,031.00
Jun 30, 2021 5,746.00
Mar 31, 2021 58,119.00
Dec 31, 2017 36,999.00
API Access

Kiora Pharmaceuticals Inc Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=KPRX&period=max&api_key=YOUR_API_KEY